Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02638766
Title Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (REGISTRI)
Acronym REGISTRI
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Grupo Espanol de Investigacion en Sarcomas
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | FRA | ESP

Facility Status City State Zip Country Details
Institute Bergonie Bordeaux France Details
Centre Leon Berard Lyon France Details
Gustave Roussy Villejuif France Details
Fondazione IRCCS Istituto Dei Tumori di Milano Milan Italy Details
Fondazione G Pascale Napoli Napoli 80131 Italy Details
Policlinico Universitario Campus Bio-Medico Roma Italy Details
Istituto di Candiolo - IRCSS Torino Italy Details
Hospital Universitario de Canarias La Laguna Santa Cruz De Tenerife 38320 Spain Details
Hospital de Cruces Barakaldo 48902 Spain Details
Hospital Universitario Vall d´hebron Barcelona 08035 Spain Details
Hospital de la Santa Creu i Sant Pau Barcelona 08041 Spain Details
Hospital Universitario Gregorio Marañon Madrid 28009 Spain Details
Hospital Universitario La Paz Madrid 28046 Spain Details
Hospital Universitario Virgen del Rocío Sevilla 41013 Spain Details
Hospital Universitario Virgen de la Macarena Sevilla 41071 Spain Details
Instituto Valenciano de Oncología Valencia 46009 Spain Details
Hospital Universitario Miguel Servet Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field